Complete Remission of Recalcitrant Plantar Wart Treated with Quadrivalent Human Papilloma Virus Vaccine

인유두종 바이러스 4가 백신($Gardasil^{(R)}$)접종으로 관해된 난치성 발바닥 사마귀

Sterling JC, Handfield-Jones S, Hudson PM. British Association of Dermatologists. Guidelines for the management of cutaneous warts. Br J Dermatol 2001;144:4-11 https://doi.org/10.1046/j.1365-2133.2001.04066.x
Venugopal SS, Murrell DF. Recalcitrant cutaneous warts treated with recombinant quadrivalent papillomavirus vaccine (type 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man. Arch Dermatol 2010;146:475-477 https://doi.org/10.1001/archdermatol.2010.71
Landis MN, Lookingbill DP, Sluzevich JC. Recalcitrant plantar warts treated with recombinant quadrivalent human papillomavirus vaccine. J AM Acad Dermatol 2012;64:373-374
Daniel BS, Murrell DF. Complete resolution of chronic multiple verruca vulgaris treated with quadrivanlent human papillomavirus vaccine. JAMA Dermatol 2013;149:370-372 https://doi.org/10.1001/jamadermatol.2013.1463
Ault KA. Human papillomavirus vaccines and the potential for cross-protection between related HPV types. Gynecol Oncol 2007;107:S31-33 https://doi.org/10.1016/j.ygyno.2007.08.059